Literature DB >> 12483522

GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity.

Shunqian Jin1, Tong Tong, Wenhong Fan, Feiyue Fan, Michael J Antinore, Xiaocheng Zhu, Lucia Mazzacurati, Xianxing Li, Kimberly L Petrik, Baskaran Rajasekaran, Min Wu, Qimin Zhan.   

Abstract

In response to DNA damage, the cell cycle checkpoint is an important biological event in maintaining genomic fidelity. Gadd45, a p53-regulated and DNA damage inducible protein, has recently been demonstrated to play a role in the G2-M checkpoint in response to DNA damage. In the current study, we further investigated the biochemical mechanism(s) involved in the GADD45-activated cell cycle G2-M arrest. Using the tetracycline-controlled system (tet-off), we established GADD45-inducible lines in HCT116 (wild-type p53) and Hela (inactivated p53 status) cells. Following inducible expression of the Gadd45 protein, cell growth was strongly suppressed in both HCT116 and Hela cells. Interestingly, HCT116 cells revealed a significant G2-M arrest but Hela cells failed to arrest at the G2-M phases, indicating that the GADD45-activated G2-M arrest requires normal p53 function. The GADD45-induced G2-M arrest was observed independent of p38 kinase activity. Importantly, induction of Gadd45 protein resulted in a reduction of nuclear cyclin B1 protein, whose nuclear localization is critical for the completion of G2-M transition. The reduced nuclear cyclin B1 levels correlated with inhibition of Cdc2/cyclin B1 kinase activity. Additionally, overexpression of cyclin B1 substantially abrogated the GADD45-induced cell growth suppression. Therefore, GADD45 inhibition of Cdc2 kinase activity through alteration of cyclin B1 subcellular localization may be an essential step in the GADD45-induced cell cycle G2-M arrest and growth suppression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12483522     DOI: 10.1038/sj.onc.1206034

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  67 in total

1.  Silibinin prevents ultraviolet B radiation-induced epidermal damages in JB6 cells and mouse skin in a p53-GADD45α-dependent manner.

Authors:  Srirupa Roy; Gagan Deep; Chapla Agarwal; Rajesh Agarwal
Journal:  Carcinogenesis       Date:  2011-12-12       Impact factor: 4.944

2.  Evolutionary emergence of a novel splice variant with an opposite effect on the cell cycle.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Mol Cell Biol       Date:  2015-04-13       Impact factor: 4.272

3.  Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells.

Authors:  Dimpy Koul; Jun Fu; Ruijun Shen; Tiffany A LaFortune; Shuzhen Wang; Ningyi Tiao; Yong-Wan Kim; Juinn-Lin Liu; Deepti Ramnarian; Ying Yuan; Carlos Garcia-Echevrria; Sauveur-Michel Maira; W K Alfred Yung
Journal:  Clin Cancer Res       Date:  2011-11-07       Impact factor: 12.531

4.  Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria.

Authors:  Tong Tong; Junfang Ji; Shunqian Jin; Xianxing Li; Wenhong Fan; Yongmei Song; Minrong Wang; Zhihua Liu; Min Wu; Qimin Zhan
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

5.  MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, MDM2.

Authors:  Yetao Jin; Shelya X Zeng; Xiao-Xin Sun; Hunjoo Lee; Christine Blattner; Zhixiong Xiao; Hua Lu
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

6.  Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT.

Authors:  Swapna Asuthkar; Arun Kumar Nalla; Christopher S Gondi; Dzung H Dinh; Meena Gujrati; Sanjeeva Mohanam; Jasti S Rao
Journal:  Neuro Oncol       Date:  2011-08-02       Impact factor: 12.300

7.  Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.

Authors:  Clara Guerzoni; Michela Bardini; Samanta A Mariani; Giovanna Ferrari-Amorotti; Paolo Neviani; Maria Luisa Panno; Ying Zhang; Robert Martinez; Danilo Perrotti; Bruno Calabretta
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

8.  Microarray analysis of DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-rays.

Authors:  Yi Qing; Xue-Qin Yang; Zhao-Yang Zhong; Xin Lei; Jia-Yin Xie; Meng-Xia Li; De-Bing Xiang; Zeng-Peng Li; Zhen-Zhou Yang; Ge Wang; Dong Wang
Journal:  BMC Cancer       Date:  2010-02-25       Impact factor: 4.430

9.  Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin.

Authors:  Elaine J Gavin; Bo Song; Yuan Wang; Yaguang Xi; Jingfang Ju
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

10.  Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor.

Authors:  Jennifer P Montgomery; Paul H Patterson
Journal:  BMC Cancer       Date:  2008-11-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.